Clinical Trial Update: The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients. [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluating DiaPep277 vaccination for Type 1 diabetes patients (Phase 1/2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• DiaPep277 (DiaPep277)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Type One Diabetes | Phase 1, Phase 2 | Status: WITHDRAWN